Turnitin
降AI改写
早检测系统
早降重系统
Turnitin-UK版
万方检测-期刊版
维普编辑部版
Grammarly检测
Paperpass检测
checkpass检测
PaperYY检测
The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
As Helicobacter pylori management has become more challenging and less efficient over
the last decade, the interest in innovative interventions is growing by the day. Probiotic co …
the last decade, the interest in innovative interventions is growing by the day. Probiotic co …
The interplay between Helicobacter pylori and gastrointestinal microbiota
The complex population of microbes in the human gastrointestinal (GI) tract interacts with
itself and with the host, exerting a deep influence on health and disease development. The …
itself and with the host, exerting a deep influence on health and disease development. The …
Seasonal shifts in the gut microbiome indicate plastic responses to diet in wild geladas
Background Adaptive shifts in gut microbiome composition are one route by which animals
adapt to seasonal changes in food availability and diet. However, outside of dietary shifts …
adapt to seasonal changes in food availability and diet. However, outside of dietary shifts …
Management of Helicobacter pylori infection: the Maastricht VI/Florence consensus report
P Malfertheiner, F Megraud, T Rokkas, JP Gisbert… - Gut, 2022 - gut.bmj.com
Helicobacter pylori Infection is formally recognised as an infectious disease, an entity that is
now included in the International Classification of Diseases 11th Revision. This in principle …
now included in the International Classification of Diseases 11th Revision. This in principle …
Effects of Helicobacter pylori infection on intestinal microbiota, immunity and colorectal cancer risk
V Engelsberger, M Gerhard… - Frontiers in Cellular and …, 2024 - frontiersin.org
Infecting about half of the world´ s population, Helicobacter pylori is one of the most
prevalent bacterial infections worldwide and the strongest known risk factor for gastric …
prevalent bacterial infections worldwide and the strongest known risk factor for gastric …
Helicobacter pylori Virulence Factors Exploiting Gastric Colonization and its Pathogenicity
Helicobacter pylori colonizes the gastric epithelial cells of at least half of the world's
population, and it is the strongest risk factor for develo** gastric complications like chronic …
population, and it is the strongest risk factor for develo** gastric complications like chronic …
Helicobacter pylori in Human Stomach: The Inconsistencies in Clinical Outcomes and the Probable Causes
SM Alexander, RJ Retnakumar, D Chouhan… - Frontiers in …, 2021 - frontiersin.org
Pathogenic potentials of the gastric pathogen, Helicobacter pylori, have been proposed,
evaluated, and confirmed by many laboratories for nearly 4 decades since its serendipitous …
evaluated, and confirmed by many laboratories for nearly 4 decades since its serendipitous …
Interaction of the microbiota with the human body in health and diseases
S Altveş, HK Yildiz, HC Vural - Bioscience of microbiota, food and …, 2020 - jstage.jst.go.jp
The human body contains many microorganisms, including a large number of bacteria,
viruses, fungi, and protozoa, which are referred to as the microbiota. Compared with the …
viruses, fungi, and protozoa, which are referred to as the microbiota. Compared with the …
Microbiota and gastric cancer
E Bessède, F Mégraud - Seminars in cancer biology, 2022 - Elsevier
The discovery of Helicobacter pylori in 1982 drew to an end the stomach being considered
as a sterile organ. Later, the progress in molecular methods, especially Next Generation …
as a sterile organ. Later, the progress in molecular methods, especially Next Generation …
Helicobacter pylori and immunotherapy for gastrointestinal cancer
K Jia, Y Chen, Y **e, X Wang, Y Hu, Y Sun, Y Cao… - The Innovation, 2024 - cell.com
Helicobacter pylori infection is associated with the risk of gastrointestinal (GI) cancers;
however, its impact on immunotherapy for GI cancers remains uncertain. In this study, we …
however, its impact on immunotherapy for GI cancers remains uncertain. In this study, we …